Kairos Pharma, LTD.
KAPA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962011
No open-market purchases or sales by Kairos Pharma, LTD. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $371.1K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Kairos Pharma, LTD. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- +3 vs. Q4 2024
- Shares held
- 1.58M
- +1.17M (+287.9%) vs. Q4 2024
- Total value
- $1.46M
- +$845.2K (+136.7%) vs. Q4 2024
- New holders
- 5
- 2 more added
- Sold out
- 2
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KAPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $371.1K |
| Q1 2026 | 11 | $341.5K |
| Q4 2025 | 14 | $607.5K |
| Q3 2025 | 14 | $505.8K |
| Q2 2025 | 10 | $172.9K |
| Q1 2025 | 8 | $1.46M |
| Q4 2024 | 5 | $618.3K |
| Q3 2024 | 2 | $70.0K |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Kairos Pharma, LTD.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,404,000 | $1.31M | 0.04% | +1,404,000 | New |
| Scientech Research LLC | 48,198 | $45.1K | 0.01% | +48,198 | New |
| Aptus Capital Advisors, LLC | 44,286 | $41.5K | 0.00% | +44,286 | New |
| SevenBridge Financial Group, LLC | 44,286 | $28.3K | 0.01% | +44,286 | New |
| Geode Capital Management, LLC | 20,433 | $19.1K | 0.00% | +20,433 | New |
| Citadel Advisors LLC | 13,230 | $12.4K | 0.00% | +2,261+20.6% | Added |
| UBS Group AG | 2,792 | $2.61K | 0.00% | −8,053−74.3% | Reduced |
| Bank of America Corp | 21 | $20 | 0.00% | +8+61.5% | Added |
| Umb Bank N A | 0 | $0 | 0.00% | −371,115−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,656−100.0% | Sold out |